10 October, 2018Europe approves Verzenios, from Lilly, for the treatment of advanced breast cancerSource: actasanitaria.com The European Commission has authorized the commercialization of Verzenios (abemaciclib), from the pharmaceutical company Lilly, as a treatment of locally advanced or metastatic breast […]